Ceva Animal health has introduced Marbox^®, a broad-spectrum anti-infective, based on marbofloxacin, for the rapid treatment of bovine mastitis and respiratory disorders. Marbox^® effectively provides two products in one bottle because it can be used as a high dose single injection or administered at a lower dose over several days.

Mastitis and respiratory disorders currently account for around 60% of antimicrobial prescriptions. Marbox^® can be used intramuscularly as a single injection for the treatment of respiratory infection. Alternatively it can be used for the treatment of acute mastitis; intravenously for the first injection and then subcutaneously at a lower dose over three days. It has a milk withdrawal of just 36 hours after subcutaneous injection.

Marbox^® is presented in an ergonomic CLAS vial which makes for light and shock-resistant handling, resulting in fewer breakages and reduced costs. It is available in 100 and 250 vial sizes and contains 100mg marbofloxacin per ml.

Marbox^® can be used in combination with Meloxidyl^®, Ceva’s new, single shot anti-inflammatory. The product joins Ceva’s popular bovine range of anti-infectives, which includes Cevaxel^®, Florkem^® and Spectam^® Injectable.

For further product information contact CEVA Animal Health Ltd, 90 The Broadway, Chesham, Bucks, HP5 1EG, telephone 01494 781510 or visit the website at www.ceva.uk.com